Search Results 131-140 of 5424 for edward loftus

  1. A Study to Assess the Effectiveness and Safety of Risankizumab in Subjects with Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Contact information: IBD Clinical Research Unit. (507) 284-5908. Closed for enrollment. More information. Publications. Publications are ...

  2. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  3. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  4. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Edward Loftus, M.D.. Contact information: Stacy Anderson R.N.. (507) 266-4728. Contact UsAnderson.Stacy@mayo.edu. Closed for enrollment. More information ...

  5. A Study of the Effectiveness of Methotrexate as Initial Treatment and Maintenance of a Steroid Free Remission in Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Efficacy of methotrexate in ulcerative colitis: failure or promise. Herfarth HH ...

  6. A Study to Evaluate the Efficacy of Low Intensity Shockwave Therapy via MoreNova in the Treatment of Erectile Dysfunction (ED). - Mayo Clinic

    The purpose of this study is to assess and evaluate the efficacy of the use of MoreNova shockwave therapy in individuals diagnosed with Erectile Dysfunction (ED) ...

  7. Publications - Fernanda Bellolio, M.D., M.S. - Mayo Clinic

    Ginsburg AD, Heaton HA, Beaudrie-Nunn A, E Silva LOJ, Canterbury E, Brown CS, Palmer AK, Cole KC, Wieruszewski ED, Bellolio F. High- versus low-dose ...

  8. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  9. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  10. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...